Prevalence and predictors of adverse events with methotrexate mono- and combination-therapy for rheumatoid arthritis: a systematic review.

Ahmad A SherbiniSeema D SharmaJames Martin Gwinnutt Kimmie L HyrichSuzanne M M Verstappen

Published in: Rheumatology (Oxford, England) (2021)

The review provides an up-to-date overview of the prevalence of AEs associated with MTX in patients with RA. The findings should be communicated to patients to help them make informed choices prior to commencing MTX.

Keyphrases

combination therapy
rheumatoid arthritis
end stage renal disease
risk factors
newly diagnosed
ejection fraction
disease activity
peritoneal dialysis
prognostic factors
low dose
systemic sclerosis